Derek Lloyd Harry Ivany - Net Worth and Insider Trading

Derek Lloyd Harry Ivany Net Worth

The estimated net worth of Derek Lloyd Harry Ivany is at least $31,000 dollars as of 2024-11-08. Derek Lloyd Harry Ivany is the 10% Security Holder, Director, Senior Officer of Nova Mentis Life Science Corp and owns about 1,240,000 shares of Nova Mentis Life Science Corp (XCNQ:NOVA) stock worth over $31,000. Details can be seen in Derek Lloyd Harry Ivany's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Derek Lloyd Harry Ivany has not made any transactions after 2023-12-14 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Derek Lloyd Harry Ivany

Derek Lloyd Harry Ivany Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Derek Lloyd Harry Ivany owns 1 companies in total, including Nova Mentis Life Science Corp (XCNQ:NOVA) .

Click here to see the complete history of Derek Lloyd Harry Ivany’s form 4 insider trades.

Insider Ownership Summary of Derek Lloyd Harry Ivany

Ticker	Comapny	Transaction Date	Type of Owner
XCNQ:NOVA	Nova Mentis Life Science Corp	2023-12-14	10% Security Holder & Director & Senior Officer

Derek Lloyd Harry Ivany Latest Holdings Summary

Derek Lloyd Harry Ivany currently owns a total of 1 stock. Derek Lloyd Harry Ivany owns 1,240,000 shares of Nova Mentis Life Science Corp (XCNQ:NOVA) as of December 14, 2023, with a value of $31,000.

Latest Holdings of Derek Lloyd Harry Ivany

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
XCNQ:NOVA	Nova Mentis Life Science Corp	2023-12-14	1,240,000	0.03	31,000

Holding Weightings of Derek Lloyd Harry Ivany

Derek Lloyd Harry Ivany Form 4 Trading Tracker

According to the SEC Form 4 filings, Derek Lloyd Harry Ivany has made a total of 17 transactions in Nova Mentis Life Science Corp (XCNQ:NOVA) over the past 5 years, including 17 buys and 0 sells. The most-recent trade in Nova Mentis Life Science Corp is the acquisition of 20,000 shares on December 14, 2023, which cost Derek Lloyd Harry Ivany around $2,500.

Insider Trading History of Derek Lloyd Harry Ivany

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Derek Lloyd Harry Ivany Trading Performance

GuruFocus tracks the stock performance after each of Derek Lloyd Harry Ivany's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Derek Lloyd Harry Ivany is -2.71%. GuruFocus also compares Derek Lloyd Harry Ivany's trading performance to market benchmark return within the same time period. The performance of stocks bought by Derek Lloyd Harry Ivany within 3 months outperforms 5 times out of 16 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Derek Lloyd Harry Ivany's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Derek Lloyd Harry Ivany

Average Return

Average return per transaction

Outperforming Transactions

0 out of 16 outperforming transactions.

Each transaction is measured over a period and compared to .

	1 Month	3 Months	6 Months	1 Year	2 Years	3 Years
Return(%)	28.61
Relative Return to S&P 500(%)	28.57

Derek Lloyd Harry Ivany Ownership Network

Ownership Network List of Derek Lloyd Harry Ivany

No Data

Ownership Network Relation of Derek Lloyd Harry Ivany

Derek Lloyd Harry Ivany Owned Company Details

What does Nova Mentis Life Science Corp do?

Who are the key executives at Nova Mentis Life Science Corp?

Derek Lloyd Harry Ivany is the 10% Security Holder & Director & Senior Officer of Nova Mentis Life Science Corp. Other key executives at Nova Mentis Life Science Corp include and Director & Senior Officer William Rascan .

Nova Mentis Life Science Corp (XCNQ:NOVA) Insider Trades Summary

Over the past 18 months, Derek Lloyd Harry Ivany made 1 insider transaction in Nova Mentis Life Science Corp (XCNQ:NOVA) with a net purchase of 100,000.

In summary, during the past 3 months, insiders sold 0 shares of Nova Mentis Life Science Corp (XCNQ:NOVA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Nova Mentis Life Science Corp (XCNQ:NOVA) were sold and 20,000 shares were bought by its insiders, resulting in a net purchase of 20,000 shares.

Nova Mentis Life Science Corp (XCNQ:NOVA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Nova Mentis Life Science Corp Insider Transactions

No Available Data

Derek Lloyd Harry Ivany Mailing Address

Above is the net worth, insider trading, and ownership report for Derek Lloyd Harry Ivany. Currently GuruFocus does not have mailing address information for Derek Lloyd Harry Ivany.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.